المؤلفون: IACCARINO, LUCA, GATTO, MARIELE, ZEN, MARGHERITA, DORIA, ANDREA, Bartoloni, Elena, Carli, Linda, Ceccarelli, Fulvia, Conti, Fabrizio, De Vita, Salvatore, Ferraccioli, Gianfranco, Galeazzi, Mauro, Gerli, Roberto, Govoni, Marcello, Gremese, Elisa, Iuliano, Annamaria, Mansutti, Elena, Moroni, Gabriella, Mosca, Marta, Nalli, Cecilia, Naretto, Carla, Padovan, Melissa, Palma, Lavinia, Raffiotta, Francesca, Roccatello, Dario, Tincani, Angela, Valesini, Guido

المساهمون: Iaccarino, Luca, Bartoloni, Elena, Carli, Linda, Ceccarelli, Fulvia, Conti, Fabrizio, De Vita, Salvatore, Ferraccioli, Gianfranco, Galeazzi, Mauro, Gatto, Mariele, Gerli, Roberto, Govoni, Marcello, Gremese, Elisa, Iuliano, Annamaria, Mansutti, Elena, Moroni, Gabriella, Mosca, Marta, Nalli, Cecilia, Naretto, Carla, Padovan, Melissa, Palma, Lavinia, Raffiotta, Francesca, Roccatello, Dario, Tincani, Angela, Valesini, Guido, Zen, Margherita, Doria, Andrea

مصطلحات موضوعية: Adult, Antibodies, Monoclonal, Murine-Derived, Antirheumatic Agent, Dose-Response Relationship, Drug, Drug Monitoring, Drug Resistance, Female, Human, Immunosuppression, Italy, Lupus Erythematosus, Systemic, Male, Middle Aged, Off-Label Use, Remission Induction, Rituximab, Severity of Illness Index, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26053285; info:eu-repo/semantics/altIdentifier/wos/WOS:000360422100001; volume:33; issue:4; firstpage:449; lastpage:456; numberofpages:8; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11577/3194819Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84939521363

الإتاحة: http://hdl.handle.net/11577/3194819Test

المؤلفون: Ferraccioli, Gianfranco, Gremese, Elisa

المساهمون: Iaccarino, L, Bartoloni, E, Carli, L, Ceccarelli, F, Conti, F, De Vita, S, Ferraccioli, Gianfranco, Galeazzi, M, Gatto, M, Gerli, R, Govoni, M, Gremese, Elisa, Iuliano, A, Mansutti, E, Moroni, G, Mosca, M, Nalli, C, Naretto, C, Padovan, M, Palma, L, Raffiotta, F, Roccatello, D, Tincani, A, Valesini, G, Zen, M, Doria, A.

مصطلحات موضوعية: Antibodies, Monoclonal, Murine-Derived, Antirheumatic Agents, Dose-Response Relationship, Drug, Drug Monitoring, Drug Resistance, Immunosuppression, Lupus Erythematosus, Systemic, Middle Aged, Off-Label Use, Remission Induction, Rituximab, Severity of Illness Index, Treatment Outcome, Settore MED/16 - REUMATOLOGIA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26053285; info:eu-repo/semantics/altIdentifier/wos/WOS:000360422100001; volume:33; issue:4; firstpage:449; lastpage:456; numberofpages:8; issueyear:2015; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/10807/71466Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84939521363

الإتاحة: http://hdl.handle.net/10807/71466Test